This inventor holds 3 USPTO granted patents. Top assignees: Olympus (Beijing) Sales & Services Co., Ltd., Olympus (Beijing) Sales & Services, Ltd., Shanghai Institute of Pharmaceutical Industry. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2025
Title: Junwei Xu: Innovator in Pharmaceutical Compounds
Introduction
Junwei Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 3 patents to his name, Xu's work is recognized for its potential impact on drug development.
Latest Patents
One of Xu's latest patents is focused on a pyridinyl morpholine compound, which includes a preparation method and its applications. This invention discloses a pyridinyl morpholine compound represented by a specific formula, along with its pharmaceutically acceptable salts and hydrates. The compound is designed to act as an antagonist for one or more of D, Dor 5-HT, and is intended for use in preparing a drug for treating schizophrenia. Another notable patent involves the development of an endoscope workstation, showcasing his versatility in innovation.
Career Highlights
Throughout his career, Junwei Xu has worked with notable companies, including Olympus (Beijing) Sales & Services Co., Ltd. and Olympus (Beijing) Sales & Services, Ltd. His experience in these organizations has contributed to his expertise in the field of medical technology and pharmaceuticals.
Collaborations
Xu has collaborated with several professionals in his field, including colleagues such as Xin Huang and Tengfei Yang. These collaborations have likely enriched his work and expanded the scope of his innovations.
Conclusion
Junwei Xu is a distinguished inventor whose work in pharmaceutical compounds has the potential to advance medical treatments. His contributions, particularly in the area of schizophrenia treatment, highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile